Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls

Journal of Proteome Research

Volumn 9, Issue 6, 2010, Pages 2996-3004

  Yap, Ivan K S ^a   Angley, Manya ^a,b   Veselkov, Kirill A ^a   Holmes, Elaine ^a   Lindon, John C ^a   Nicholson, Jeremy K ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

autism; gut microbiota; metabolic phenotype; metabolic profiling; metabonomics; microbial co metabolites; NMR; pattern recognition

Indexed keywords

AMINO ACID; GLUTAMIC ACID; N METHYLNICOTINAMIDE; NICOTINIC ACID; SULFUR; TAURINE; TRIGONELLINE; TRYPTOPHAN;

ARTICLE; AUTISM; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIGNAL TRANSDUCTION; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

AMINO ACIDS; AUTISTIC DISORDER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CREATININE; FEMALE; HUMANS; MALE; METABOLOME; METABOLOMICS; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PATTERN RECOGNITION, AUTOMATED; PRINCIPAL COMPONENT ANALYSIS; SIBLINGS;

EID: 77954592502     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr901188e     Document Type: Article

References (64)

1. Angley, M.; Young, R.; Ellis, D.; Chan, W.; McKinnon, R. Children and autism-Part 1-recognition and pharmacological management. Aust. Fam. Physician 2007, 36 (9), 741-744
2. Johnson, C. P.; Myers, S. M. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007, 120 (5), 1183-1215
3. Morrow, E. M.; Yoo, S. Y.; Flavell, S. W.; Kim, T. K.; Lin, Y.; Hill, R. S.; Mukaddes, N. M.; Balkhy, S.; Gascon, G.; Hashmi, A.; Al-Saad, S.; Ware, J.; Joseph, R. M.; Greenblatt, R.; Gleason, D.; Ertelt, J. A.; Apse, K. A.; Bodell, A.; Partlow, J. N.; Barry, B.; Yao, H.; Markianos, K.; Ferland, R. J.; Greenberg, M. E.; Walsh, C. A. Identifying autism loci and genes by tracing recent shared ancestry. Science 2008, 321 (5886), 218-223
4. Wang, K.; Zhang, H.; Ma, D.; Bucan, M.; Glessner, J. T.; Abrahams, B. S.; Salyakina, D.; Imielinski, M.; Bradfield, J. P.; Sleiman, P. M.; Kim, C. E.; Hou, C.; Frackelton, E.; Chiavacci, R.; Takahashi, N.; Sakurai, T.; Rappaport, E.; Lajonchere, C. M.; Munson, J.; Estes, A.; Korvatska, O.; Piven, J.; Sonnenblick, L. I.; Alvarez Retuerto, A. I.; Herman, E. I.; Dong, H.; Hutman, T.; Sigman, M.; Ozonoff, S.; Klin, A.; Owley, T.; Sweeney, J. A.; Brune, C. W.; Cantor, R. M.; Bernier, R.; Gilbert, J. R.; Cuccaro, M. L.; McMahon, W. M.; Miller, J.; State, M. W.; Wassink, T. H.; Coon, H.; Levy, S. E.; Schultz, R. T.; Nurnberger, J. I.; Haines, J. L.; Sutcliffe, J. S.; Cook, E. H.; Minshew, N. J.; Buxbaum, J. D.; Dawson, G.; Grant, S. F.; Geschwind, D. H.; Pericak-Vance, M. A.; Schellenberg, G. D.; Hakonarson, H. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009, 459 (7246), 528-533
5. Kidd, P. M. Autism, an extreme challenge to integrative medicine. Part: 1: The knowledge base. Altern. Med. Rev. 2002, 7 (4), 292-316.
6. Ashwood, P.; Anthony, A.; Pellicer, A. A.; Torrente, F.; Walker-Smith, J. A.; Wakefield, A. J. Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J. Clin. Immunol. 2003, 23 (6), 504-517
7. Chugani, D. C.; Sundram, B. S.; Behen, M.; Lee, M. L.; Moore, G. J. Evidence of altered energy metabolism in autistic children. Prog. Neuropsychopharmacol. Biol. Psychiatry 1999, 23 (4), 635-641
8. Levy, S. E.; Souders, M. C.; Ittenbach, R. F.; Giarelli, E.; Mulberg, A. E.; Pinto-Martin, J. A. Relationship of dietary intake to gastrointestinal symptoms in children with autistic spectrum disorders. Biol. Psychiatry 2007, 61 (4), 492-497
9. Bolte, E. R. Autism and Clostridium tetani. Med. Hypotheses 1998, 51 (2), 133-144
10. Martin, F. P.; Wang, Y.; Sprenger, N.; Yap, I. K.; Lundstedt, T.; Lek, P.; Rezzi, S.; Ramadan, Z.; van Bladeren, P.; Fay, L. B.; Kochhar, S.; Lindon, J. C.; Holmes, E.; Nicholson, J. K. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol. Syst. Biol. 2008, 4, 157.
11. Parracho, H. M.; Bingham, M. O.; Gibson, G. R.; McCartney, A. L. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J. Med. Microbiol. 2005, 54 (10), 987-991
12. Yap, I. K.; Li, J. V.; Saric, J.; Martin, F. P.; Davies, H.; Wang, Y.; Wilson, I. D.; Nicholson, J. K.; Utzinger, J.; Marchesi, J. R.; Holmes, E. Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. J. Proteome Res. 2008, 7 (9), 3718-3728
13. Finegold, S. M.; Molitoris, D.; Song, Y.; Liu, C.; Vaisanen, M. L.; Bolte, E.; McTeague, M.; Sandler, R.; Wexler, H.; Marlowe, E. M.; Collins, M. D.; Lawson, P. A.; Summanen, P.; Baysallar, M.; Tomzynski, T. J.; Read, E.; Johnson, E.; Rolfe, R.; Nasir, P.; Shah, H.; Haake, D. A.; Manning, P.; Kaul, A. Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 2002, 35 (1), S6-S16.
14. Ryaskin, O. T. Trends in autism research; Nova Biomedical Books: New York, 2004; pp xi, 236.
15. Baron-Cohen, S.; Scott, F. J.; Allison, C.; Williams, J.; Bolton, P.; Matthews, F. E.; Brayne, C. Prevalence of autism-spectrum conditions: UK school-based population study. Br. J. Psychiatry 2009, 194 (6), 500-509
16. Gurney, J. G.; McPheeters, M. L.; Davis, M. M. Parental report of health conditions and health care use among children with and without autism: National Survey of Children's Health. Arch. Pediatr. Adolesc. Med. 2006, 160 (8), 825-830
17. Dyches, T. T.; Wilder, L. K.; Sudweeks, R. R.; Obiakor, F. E.; Algozzine, B. Multicultural issues in autism. J. Autism Dev. Disord. 2004, 34 (2), 211-222
18. American Psychiatric Association. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR, 4th ed.; American Psychiatric Association: Washington, DC, 2000; pp xxxvii, 943.
19. Nicholson, J. K.; Connelly, J.; Lindon, J. C.; Holmes, E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 2002, 1 (2), 153-161
20. Nicholson, J. K.; Lindon, J. C.; Holmes, E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29 (11), 1181-1189
21. Skordi, E.; Yap, I. K.; Claus, S. P.; Martin, F. P.; Cloarec, O.; Lindberg, J.; Schuppe-Koistinen, I.; Holmes, E.; Nicholson, J. K. Analysis of time-related metabolic fluctuations induced by ethionine in the rat. J. Proteome Res. 2007, 6 (12), 4572-4581
22. Yap, I. K.; Clayton, T. A.; Tang, H.; Everett, J. R.; Hanton, G.; Provost, J. P.; Le Net, J. L.; Charuel, C.; Lindon, J. C.; Nicholson, J. K. An integrated metabonomic approach to describe temporal metabolic disregulation induced in the rat by the model hepatotoxin allyl formate. J. Proteome Res. 2006, 5 (10), 2675-2684
23. Fan, T. W. M. Metabolite profiling by one-and two-dimensional NMR analysis of complex mixtures. Prog. Nucl. Magn. Reson. Spectrosc. 1996, 28 (2), 161-219.
24. Nicholson, J. K.; Foxall, P. J.; Spraul, M.; Farrant, R. D.; Lindon, J. C. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal. Chem. 1995, 67 (5), 793-811.
25. Cloarec, O.; Dumas, M. E.; Craig, A.; Barton, R. H.; Trygg, J.; Hudson, J.; Blancher, C.; Gauguier, D.; Lindon, J. C.; Holmes, E.; Nicholson, J. Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Anal. Chem. 2005, 77 (5), 1282-1289
26. Veselkov, K. A.; Lindon, J. C.; Ebbels, T. M.; Crockford, D.; Volynkin, V. V.; Holmes, E.; Davies, D. B.; Nicholson, J. K. Recursive segmentwise peak alignment of biological (1)h NMR spectra for improved metabolic biomarker recovery. Anal. Chem. 2009, 81 (1), 56-66.
27. Trygg, J.; Wold, S. Orthogonal projections to latent structures (OPLS). J. Chemom. 2002, 16 (3), 119-128
28. Cloarec, O.; Dumas, M. E.; Trygg, J.; Craig, A.; Barton, R. H.; Lindon, J. C.; Nicholson, J. K.; Holmes, E. Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. Anal. Chem. 2005, 77 (2), 517-526
29. Fisher, R. A. The design of experiments; Oliver and Boyde: Edinburgh, London, 1935; pp xi, 252.
30. Pitman, E. J. G., III. The analysis of variance test. Biometrika 1938, 29 (3-4), 322-335.
31. Diaz, E.; Ferrandez, A.; Prieto, M. A.; Garcia, J. L. Biodegradation of aromatic compounds by Escherichia coli. Microbiol. Mol. Biol. Rev. 2001, 65 (4), 523-569, and table of contents.
32. Nicholson, J. K.; Holmes, E.; Wilson, I. D. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 2005, 3 (5), 431-438
33. Schwab, A. J.; Tao, L.; Yoshimura, T.; Simard, A.; Barker, F.; Pang, K. S. Hepatic uptake and metabolism of benzoate: a multiple indicator dilution, perfused rat liver study. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280 (6), G1124-36.
34. Selmer, T.; Andrei, P. I. p-Hydroxyphenylacetate decarboxylase from Clostridium difficile. A novel glycyl radical enzyme catalysing the formation of p-cresol. Eur. J. Biochem. 2001, 268 (5), 1363-1372
35. Backhed, F.; Ding, H.; Wang, T.; Hooper, L. V.; Koh, G. Y.; Nagy, A.; Semenkovich, C. F.; Gordon, J. I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 2004, 101 (44), 15718-15723
36. Nicholls, A. W.; Mortishire-Smith, R. J.; Nicholson, J. K. NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem. Res. Toxicol. 2003, 16 (11), 1395-1404
37. Lenz, E. M.; Bright, J.; Knight, R.; Westwood, F. R.; Davies, D.; Major, H.; Wilson, I. D. Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers 2005, 10 (2-3), 173-187
38. Lis, A. W.; McLaughlin, I.; Mpclaughlin, R. K.; Lis, E. W.; Stubbs, E. G. Profiles of ultraviolet-absorbing components of urine from autistic children, as obtained by high-resolution ion-exchange chromatography. Clin. Chem. 1976, 22 (9), 1528-1532
39. Aldred, S.; Moore, K. M.; Fitzgerald, M.; Waring, R. H. Plasma amino acid levels in children with autism and their families. J. Autism Dev. Disord. 2003, 33 (1), 93-97
40. Evans, C.; Dunstan, R. H.; Rothkirch, T.; Roberts, T. K.; Reichelt, K. L.; Cosford, R.; Deed, G.; Ellis, L. B.; Sparkes, D. L. Altered amino acid excretion in children with autism. Nutr. Neurosci. 2008, 11 (1), 9-17.
41. Rolf, L. H.; Haarmann, F. Y.; Grotemeyer, K. H.; Kehrer, H. Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr. Scand. 1993, 87 (5), 312-316
42. Arnold, G. L.; Hyman, S. L.; Mooney, R. A.; Kirby, R. S. Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies. J. Autism Dev. Disord. 2003, 33 (4), 449-454
43. Stadnyk, A.; Gauldie, J. The acute phase protein response during parasitic infection. Immunol. Today 1991, 12 (3), A7-12.
44. Montgomerie, J. Z.; Holshuh, H. J.; Keyser, A. J.; Bennett, C. J.; Schick, D. G. 28 K in squamous metaplasia of the bladder in patients with spinal cord injury. Paraplegia 1993, 31 (2), 105-110
45. Mostafa, G. A.; El-Sayed, Z. A.; El-Aziz, M. M.; El-Sayed, M. F. Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children. J. Child Neurol. 2008, 23 (12), 1413-1418
46. Wolf, H. The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway. Scand. J. Clin. Lab. Invest. 1974, 136, 1-186.
47. Ringeissen, S.; Connor, S. C.; Brown, H. R.; Sweatman, B. C.; Hodson, M. P.; Kenny, S. P.; Haworth, R. I.; McGill, P.; Price, M. A.; Aylott, M. C.; Nunez, D. J.; Haselden, J. N.; Waterfield, C. J. Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: identification of N-methylnicotinamide and N-methyl-4-pyridone-3-carboxamide by 1H nuclear magnetic resonance and high performance liquid chromatography. Biomarkers 2003, 8 (3-4), 240-271
48. Willets, J. M.; Lunec, J.; Williams, A. C.; Griffiths, H. R. Neurotoxicity of nicotinamide derivatives: their role in the aetiology of Parkinson's disease. Biochem. Soc. Trans. 1993, 21 (3), 299S.
49. Williams, A.; Sturman, S.; Steventon, G.; Waring, R. Metabolic biomarkers of Parkinson's disease. Acta Neurol. Scand. Suppl. 1991, 136, 19-23.
50. Williams, A. C.; Pall, H. S.; Steventon, G. B.; Green, S.; Buttrum, S.; Molloy, H.; Waring, R. H. N-methylation of pyridines and Parkinson's disease. Adv. Neurol. 1993, 60, 194-196
51. Fukushima, T.; Kaetsu, A.; Lim, H.; Moriyama, M. Possible role of 1-methylnicotinamide in the pathogenesis of Parkinson's disease. Exp. Toxicol. Pathol. 2002, 53 (6), 469-473
52. Fukushima, T.; Tawara, T.; Isobe, A.; Hojo, N.; Shiwaku, K.; Yamane, Y. Radical formation site of cerebral complex I and Parkinson's disease. J. Neurosci. Res. 1995, 42 (3), 385-390
53. Mizuno, Y.; Ohta, S.; Tanaka, M.; Takamiya, S.; Suzuki, K.; Sato, T.; Oya, H.; Ozawa, T.; Kagawa, Y. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 1989, 163 (3), 1450-1455
54. Parker, W. D., Jr.; Boyson, S. J.; Parks, J. K. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 1989, 26 (6), 719-723
55. Schapira, A. H.; Mann, V. M.; Cooper, J. M.; Dexter, D.; Daniel, S. E.; Jenner, P.; Clark, J. B.; Marsden, C. D. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 1990, 55 (6), 2142-2145
56. Paavonen, E. J.; Nieminen-von Wendt, T.; Vanhala, R.; Aronen, E. T.; von Wendt, L. Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder. J. Child. Adolesc. Psychopharmacol. 2003, 13 (1), 83-95.
57. Hanley, H. G.; Stahl, S. M.; Freedman, D. X. Hyperserotonemia and amine metabolites in autistic and retarded children. Arch. Gen. Psychiatry 1977, 34 (5), 521-531
58. Hoshino, Y.; Yamamoto, T.; Kaneko, M.; Tachibana, R.; Watanabe, M.; Ono, Y.; Kumashiro, H. Blood serotonin and free tryptophan concentration in autistic children. Neuropsychobiology 1984, 11 (1), 22-27
59. Melke, J.; Goubran Botros, H.; Chaste, P.; Betancur, C.; Nygren, G.; Anckarsater, H.; Rastam, M.; Stahlberg, O.; Gillberg, I. C.; Delorme, R.; Chabane, N.; Mouren-Simeoni, M. C.; Fauchereau, F.; Durand, C. M.; Chevalier, F.; Drouot, X.; Collet, C.; Launay, J. M.; Leboyer, M.; Gillberg, C.; Bourgeron, T. Abnormal melatonin synthesis in autism spectrum disorders. Mol. Psychiatry 2008, 13 (1), 90-98
60. James, S. J.; Cutler, P.; Melnyk, S.; Jernigan, S.; Janak, L.; Gaylor, D. W.; Neubrander, J. A. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 2004, 80 (6), 1611-1617
61. James, S. J.; Melnyk, S.; Jernigan, S.; Hubanks, A.; Rose, S.; Gaylor, D. W. Abnormal transmethylation/transsulfuration metabolism and DNA hypomethylation among parents of children with autism. J. Autism Dev. Disord. 2008, 38 (10), 1966-1975
62. Chauhan, A.; Chauhan, V. Oxidative stress in autism. Pathophysiology 2006, 13 (3), 171-181
63. James, S. J.; Melnyk, S.; Jernigan, S.; Cleves, M. A.; Halsted, C. H.; Wong, D. H.; Cutler, P.; Bock, K.; Boris, M.; Bradstreet, J. J.; Baker, S. M.; Gaylor, D. W. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am. J. Med. Genet., Part B 2006, 141B (8), 947-956
64. Clayton, T. A.; Baker, D.; Lindon, J. C.; Everett, J. R.; Nicholson, J. K. Pharmacometabonomic identification of a significant hostmicrobiome metabolic interaction affecting human drug metabolism. Proc. Natl. Acad. Sci. USA 2009, 106 (34), 14728-14733